Home
SION
SION News

Latest SIONNA THERAPEUTICS INC (SION) News on May 9, 2025

While individual investors own 26% of Sionna Therapeutics, Inc. (NASDAQ:SION), private equity firms are its largest shareholders with 56% ownership

Simply Wall St.

a day ago

While individual investors own 26% of Sionna Therapeutics, Inc. (NASDAQ:SION), private equity firms are its largest shareholders with 56% ownership

Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025

GlobeNewswire

9 days ago

Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025

MT Newswires

a month ago

Top Premarket Decliners

MT Newswires

a month ago

Top Premarket Decliners

Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

2 months ago

Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month

Insider Monkey

2 months ago

Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month

Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently?

Insider Monkey

2 months ago

Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently?

Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently

Insider Monkey

2 months ago

Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market

Pharmaceutical Technology

2 months ago

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market

Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference

GlobeNewswire

3 months ago

Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference

Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year?

Insider Monkey

3 months ago

Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year?

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

3 months ago

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Share on Social Networks: